Thomas Adams Ph.D., Director at Trovagene, Inc. (TROV), sold 19,200 shares at $8.64 ($157K) on 2013-09-03, disclosed to the SEC on 2013-09-04.
Open-market sale of $157k TROV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.06 | 15,000 | $121K | 76.9% |
| 2 | $8.64 | 4,200 | $36K | 23.1% |
| Total | $8.19 avg | 19,200 | $157K | 100% |
| Filing → |
| IRIS | SELL | 2011-06-20 | $184K | — | Filing → |
| IRIS | SELL | 2007-09-20 | $330K | — | Filing → |